← Back to feedRead original →
VERIFIEDET Finance·positive
Zydus Lifesciences gets USFDA nod for generic ascorbic acid injection
AI Summary
- ·Zydus Lifesciences has received final USFDA approval for its generic ascorbic acid injection.
- ·The injection is approved for the treatment of scurvy in specific patient groups.
- ·The USFDA designated this application as a Competitive Generic Therapy.